1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
694F1141E8CC3293C8525734F005241B3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/pharmaceutical-market-analytics-stakeholders-and-corporate-recognition-support?opendocument
18
19opendocument
2034.228.38.35
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Market Research, Analytics and Forecasting Building Influence and Enhancing Business Value

Pharmaceutical Market Analytics: Stakeholders and Corporate Recognition & Support

DB Image

ID: 4975


Features:

Metrics, Graphics


Pages/Slides: 22


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

Non-members: Click here to sign-up for a complimentary tour of
"Pharmaceutical Market Analytics: Stakeholders and Corporate Recognition & Support"


STUDY OVERVIEW
Despite its potential to have great impact on the business, Market Analytics (see Key Definitions below) frequently has to work hard to achieve adequate recognition and resources from top management, which historically has viewed marketing and sales as the top priority. Market Analytics leaders achieve recognition by networking and cultivating trust with key stakeholders and delivering top quality insights and analyses. Executives who oversee Market Analytics activities can use this research document to understand who are the key internal customers and collaborators for analytics and learn tactics that functional leaders use to align their work with corporate needs to deliver top value and build trust.

KEY TOPICS
Executive Summary
Building Effective Relationships with Key Stakeholders
Winning Corporate Recognition and Support
Appendix A: Top Lessons Learned

KEY METRICS
Primary and Secondary Users of Forecasting, Sales, Marketing and Business Development Analytics
Key Collaborators on Forecasting, Sales, Marketing, and Business Development Analyses
Tactics for Effective Stakeholder Communication
Best Practices for Aligning with Stakeholder Needs
Effective Methods for Evaluating Internal Customer Satisfaction
Measuring Analytics Performance

SAMPLE KEY FINDINGS
Interviewed benchmark partners find that clear and continuous communication with stakeholders is vital for building strong relationships. Leaders use such practices as involving internal users early in the project design process and holding debriefings after major projects are completed.
A lesson learned shared one study participant is to keep the voice of the external customer deeply rooted in all analyses.

STUDY METHODOLOGY
Best Practices, LLC completed this study in two phases — an online survey and telephone interviews. Researchers surveyed managers and executives from 21 leading pharmaceutical, medical device and biotechnology companies to collect benchmark metrics. The research team also conducted in-depth interviews with selected program leaders at six of the surveyed organizations. Best Practices used interviews to surface executive insights and winning practices companies use to evolve the analytics functions to build effective relationships with internal customers and collaborators and to win corporate recognition and support for analytics.

KEY DEFINITIONS
“Market Analytics” is used broadly to encompass a range of activities usually conducted in such departments as Market Research, Market Analytics, Business/ Commercial/Franchise/Brand Analytics, Business Development, Competitive/Business/Market Intelligence, Sales or Sales Operations, Pricing, Forecasting, Marketing, or Finance. This study focuses on individual analytics activities rather than on departments where they may or may not be performed; analytics functions are rarely all centralized in a single department.


Industries Profiled:
Pharmaceutical; Biotech; Health Care; Consumer Products


Companies Profiled:
Abbott Laboratories; Alcon; Amgen; Amylin; Aton Pharma; Boehringer Ingelheim; Cubist Pharmaceuticals; DSM Pharmaceutical; Eisai; Eli Lilly; Genzyme; Mead Johnson; Medrad; Novartis Canada; Ortho Biotech; Purdue Pharma; Sanofi-aventis; Sepracor; Shire; Vertex Pharmaceuticals; Xanodyne Pharmaceuticals


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.